NEW YORK, Oct. 21, 2016 -- Guggenheim Investments, the global asset management and investment advisory business of Guggenheim Partners, today announced it will complete transition of underlying indices for Guggenheim Defensive Equity ETF (DEF) and Guggenheim Insider Sentiment ETF (NFO) effective October 24, 2016.
The names and ticker symbols of both ETFs remain the same.
| Ticker | Name | New Index | Previous Index |
| DEF | Guggenheim Defensive Equity ETF | Guggenheim Defensive Equity Index | Sabrient Defensive Equity Index |
| NFO | Guggenheim Insider Sentiment ETF | Nasdaq US Insider Sentiment Index | Sabrient Insider Sentiment Index |
For more information, please visit http://www.guggenheiminvestments.com/etf or call 888.WHY.ETFs to speak to a representative.
About Guggenheim Investments
Guggenheim Investments is the global asset management and investment advisory division of Guggenheim Partners, with $202 billion1 in assets across fixed income, equity, and alternative strategies. We focus on the return and risk needs of insurance companies, corporate and public pension funds, sovereign wealth funds, endowments and foundations, consultants, wealth managers, and high-net-worth investors. Our 275+ investment professionals perform rigorous research to understand market trends and identify undervalued opportunities in areas that are often complex and underfollowed. This approach to investment management has enabled us to deliver innovative strategies providing diversification and attractive long-term results.
1Guggenheim Investments total asset figure is as of 06.30.2016. The assets include leverage of $11.4bn for assets under management and $0.5bn for assets for which we provide administrative services. Guggenheim Investments represents the following affiliated investment management businesses: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Real Estate, LLC, Transparent Value Advisors, LLC, GS GAMMA Advisors, LLC, Guggenheim Partners Europe Limited and Guggenheim Partners India Management.
RISK CONSIDERATIONS
Stock markets can be volatile. Investments in securities of small and medium capitalization companies may involve greater risk of loss and more abrupt fluctuations in market price than investments in larger companies. DEF seeks to track a quantitative strategy index, created by a proprietary model, and its success depends on the effectiveness of the model. As a result, the fund could have a lower return than if it were managed using a fundamental investment strategy that did not incorporate quantitative analysis.
Index Disclaimer: Guggenheim Defensive Equity Index is a trademark of Accretive Asset Management LLC. Accretive Asset Management, LLC is an affiliate of Guggenheim Investments. Nasdaq and “Nasdaq US Insider Sentiment” are trademarks of Nasdaq, Inc. (which with its affiliates is referred to as the “Corporations”) and are licensed for use by Guggenheim Investments. The fund has not been passed on by the Corporations as to their legality or suitability. Guggenheim funds are not issued, endorsed, sold, or promoted by the Corporations. THE CORPORATIONS MAKE NO WARRANTIES AND BEAR NO LIABILITY WITH RESPECT TO GUGGENHEIM INVESTMENTS FUNDS.
Read a fund’s prospectus and summary prospectus (if available) carefully before investing. It contains the fund’s investment objectives, risks, charges, expenses and other information, which should be considered carefully before investing. Obtain a prospectus and summary prospectus (if available) at www.guggenheiminvestments.com or call 800.820.0888.
The referenced funds are distributed by Guggenheim Funds Distributors, LLC. Guggenheim Investments represents the investment management businesses of Guggenheim Partners (“Guggenheim”), which includes Guggenheim Funds Investment Advisors, LLC ("GFIA"), the investment advisor to the referenced funds. Guggenheim Funds Distributors, LLC is affiliated with Guggenheim and GFIA.
PR-NFODEF
Media Contact Ivy McLemore Guggenheim Partners 212.518.9859 [email protected]


Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
FDA Approves Mitapivat for Anemia in Thalassemia Patients
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing 



